Glenmark Pharma Rallies 9% On DCGI Approval For Covid 19 Trial

Shares of Glenmark Pharmaceuticals in intra-day trade on April 30, 2020 rallied a whopping 9% as it became the first company to receive the Drug Controller General of India (DCGI) approval for conducting trials of tablets for treatment against Covid

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/2KMXmeP